gallocatechol has been researched along with Carcinoma, Squamous Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baran, I; Ganea, C; Georgescu, L; Katona, E; Mocanu, MM; Nagy, P; Shrestha, D; Szöllősi, J; Váradi, T | 1 |
Babich, H; Krupka, ME; Nissim, HA; Zuckerbraun, HL | 1 |
Agarwal, R; Katiyar, SK; Mohan, RR; Mukhtar, H | 1 |
3 other study(ies) available for gallocatechol and Carcinoma, Squamous Cell
Article | Year |
---|---|
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
Topics: Algorithms; Anticarcinogenic Agents; Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Proliferation; Down-Regulation; ErbB Receptors; Female; Flavonoids; G2 Phase Cell Cycle Checkpoints; Genes, erbB-1; Genes, erbB-2; Genistein; Glycine max; Humans; Molecular Structure; Polyphenols; Receptors, Laminin; Ribosomal Proteins; Tea | 2014 |
Differential in vitro cytotoxicity of (-)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity.
Topics: Antioxidants; Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Survival; DNA; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fibroblasts; Gingiva; Humans; Mouth Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2005 |
Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antioxidants; Carcinoma, Squamous Cell; Catechin; Cocarcinogenesis; Disease Progression; Diterpenes; Flavonoids; Mice; Mice, Inbred SENCAR; Papilloma; Phenols; Plant Extracts; Polymers; Skin Neoplasms; Tea; Terpenes | 1997 |